Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis and predictors
暂无分享,去创建一个
F. Maisano | D. Capodanno | D. Antoniucci | M. Napodano | A. Poli | C. Tamburino | A. Ramondo | A. Petronio | F. Ettori | G. Santoro | S. Klugmann | F. Bedogni | A. Marzocchi | C. Fiorina | G. Ussia | M. Carlo
[1] H. Eggebrecht,et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. , 2011, European heart journal.
[2] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[3] Thomas Walther,et al. Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve , 2010, Circulation.
[4] A. Yan,et al. Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease. , 2010, The American journal of cardiology.
[5] D. Capodanno,et al. Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation. , 2010, The Journal of invasive cardiology.
[6] Fabian Nietlispach,et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.
[7] B. Bouma,et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. , 2010, American heart journal.
[8] Navid Madershahian,et al. Minimally invasive transapical aortic valve implantation and the risk of acute kidney injury. , 2010, The Annals of thoracic surgery.
[9] J. Suárez de Lezo,et al. Percutaneous implantation of the CoreValve self-expanding aortic valve prosthesis in patients with severe aortic stenosis: early experience in Spain. , 2010, Revista espanola de cardiologia.
[10] Philippe Pibarot,et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement , 2009, European heart journal.
[11] Bijoy K Khandheria,et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Card , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[12] Fabian Nietlispach,et al. Transcatheter Aortic Valve Implantation: Impact on Clinical and Valve-Related Outcomes , 2009, Circulation.
[13] A. Cribier,et al. Outcomes and safety of percutaneous aortic valve replacement. , 2009, Journal of the American College of Cardiology.
[14] D. Capodanno,et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. , 2009, The Journal of invasive cardiology.
[15] D. Capodanno,et al. Early Conduction Disorders Following Percutaneous Aortic Valve Replacement , 2009, Pacing and clinical electrophysiology : PACE.
[16] T. Felderhoff,et al. Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System , 2008, Circulation. Cardiovascular interventions.
[17] T. Sundt,et al. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? , 2008, The Journal of thoracic and cardiovascular surgery.
[18] P. Serruys,et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[19] J. Mayer,et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[20] A. Ducharme,et al. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. , 2007, The Journal of thoracic and cardiovascular surgery.
[21] Lukas Altwegg,et al. Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.
[22] Thomas Walther,et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.
[23] A. Garg,et al. Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.
[24] A. Cribier,et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.
[25] M. Viitanen,et al. Poor Outcome After First-Ever Stroke: Predictors for Death, Dependency, and Recurrent Stroke Within the First Year , 2003, Stroke.
[26] Assaf Bash,et al. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.